Stock Option Challenges and Opportunities: Expirations, Extensions, Repricings and Regrants
30 November 2023
Stock options remain a popular vehicle for delivering compensation that aligns employee and shareholder incentives and creates an ownership mentality, but they are not always trouble free.
Foley’s Employee Benefits & Executive Compensation team invites you to attend this informative webinar that will summarize and provide practical advice for how to address some common challenges of stock option programs:
- What rules apply to option pricing, and why is this so important?
- What happens if the value of the stock declines rather than increases, leaving option holders with “underwater” options that can undermine rather than create morale?
- How should a company respond to a situation in which options are significantly in-the-money but are likely to expire before there is a liquidity event?
This webinar will survey these, and some other common challenges confronted by stock option programs and provide practical advice for how to address them.
To register, please click here.
People
Related Insights
24 July 2025
Events
ACI's Inaugural Summit on GLP-1 Law & Policy
Foley partner Kyle Faget, co-chair of the firm’s Medical Devices Area of Focus, is speaking in American Conference Institute’s Inaugural Summit on GLP-1 Law & Policy on July 24.
23 April 2025
Tariff & International Trade Resource
What Every Multinational Company Should Know About…Tariff Strategies for Sell-Side Contracts
With the size and scope of President Trump’s tariffs continuing to shift, this is a critical time for businesses to assess their contracts and determine how increased tariff costs might adversely affect profitability, and whether there are any strategies to mitigate the losses.
22 April 2025
Health Care Law Today
Health Care Marketing: The Seventh Circuit Addresses “Referrals” Under The Anti-Kickback Statute
The case, United States v. Sorenson, addressed whether a Medicare-registered distributor violated the AKS in making payments to advertising, marketing, and manufacturing companies that worked to sell orthopedic braces to Medicare patients. The court held that such payments were not “referrals” within the meaning of the AKS because the payments were made to entities that were neither physicians in a position to refer their patients nor other decisionmakers in positions to “leverage fluid, informal power and influence” over health care decisions.